Eric Crombez
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Eric Crombez
Eric Crombez is recorded as Board Member at Abeona Therapeutics Inc. (ABEO). Abeona Therapeutics Inc. reported in an 8-K filed August 14, 2024 that Eric Crombez was appointed member of the Board, effective August 12, 2024. The proxy statement of Ultragenyx Pharmaceutical Inc. reports total compensation of $4,002,173 for Eric Crombez in fiscal 2025, including a base salary of $630,231. Disclosed compensation is on record for 2 fiscal years. Eric Crombez has spoken on 2 earnings calls and 3 other investor events across 1 company, most recently for Ultragenyx Pharmaceutical Inc. on September 17, 2026.
“appointed Bernhardt G. Zeiher, MD, FCCP, FACP, on August 8, 2024 and Eric Crombez, MD on August 12, 2024 as members of the Board of the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
-
Ultragenyx Pharmaceutical Inc. (RARE)
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Ultragenyx Pharmaceutical Inc.
Other people whose current roles at this company are on record from its filings.
- Emil D. Kakkis CEO, Board Member
- Emil Kakkis CEO, Board Member
- Howard Horn CFO
- Eric Crombez, M.D. CTO
- Karah Parschauer General Counsel
- Amrit Ray, M.D. Board Member
- Clay B. Siegall Board Member
- Continuing Directors Board Member
- Corazon (Corsee) D. Sanders, Ph.D. Board Member
- Corsee Sanders, Ph.D. Board Member
Leadership on record at Abeona Therapeutics Inc.
Other people whose current roles at this company are on record from its filings.
- Michael Amoroso CEO, Chairman, COO, Board Member
- Vishwas Seshadri CEO, Board Member
- Brian J.G. Pereira Chairman, Board Member
- Edward Carr CFO
- Joseph Vazzano CFO
- Brendan O’Malley General Counsel
- Bernhardt G. Zeiher Board Member
- Christine Berni Silverstein Board Member
- Christine Silverstein Board Member
- Donald A. Wuchterl Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Ultragenyx Pharmaceutical Inc. (RARE) | Chief Medical Officer and Executive Vice President | $630,231 | $4,002,173 |
| 2024 | Ultragenyx Pharmaceutical Inc. (RARE) | Chief Medical Officer and Executive Vice President | $591,846 | $4,298,223 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.